8-K: PACS Group Amends Credit Agreement and Receives NYSE Extension Amid Ongoing Filing Delays and Audit Investigation

PACS Group, Inc. has amended its credit agreement to extend financial statement delivery deadlines and received an extension from the NYSE to regain compliance, as the company continues to delay multiple SEC filings due to an ongoing independent audit investigation.

Summary

• PACS Group, Inc. and its subsidiary, PACS Holdings, LLC, entered into an amendment to their Amended and Restated Credit Agreement on May 29, 2025, with Truist Bank and other lenders.
• The amendment modifies the affirmative covenant for delivering audited annual financial statements, extending the deadline for the fiscal year ended December 31, 2024, from 90 days to 195 days after year-end, with potential for further extensions up to 225 days or more with lender agreement.
• A new financial covenant requires the Company and its subsidiaries to maintain at least $100.0 million in unrestricted cash and certain permitted investments until the audited financial statements for fiscal year 2024 are delivered.
• The Company has previously disclosed its inability to timely file its Quarterly Report on Form 10-Q for Q3 2024, Annual Report on Form 10-K for FY 2024, and Quarterly Report on Form 10-Q for Q1 2025 (collectively, the 'Delinquent Filings').
• These delays are attributed to an ongoing independent investigation by the Company's independent Audit Committee.
• The New York Stock Exchange (NYSE) issued a notice of noncompliance on November 26, 2024, due to the delayed Q3 2024 10-Q filing.
• On May 20, 2025, the NYSE granted PACS Group an additional trading period through September 2, 2025, to regain compliance, subject to ongoing reassessment.
• The maximum 12-month cure period for all Delinquent Filings with the NYSE expires on November 19, 2025.
• The Company intends to file the Delinquent Filings and regain compliance as soon as feasible within the granted period, but there is no assurance it will ultimately regain compliance with all NYSE listing standards.

Sentiment

Score: 3

Explanation: The sentiment is predominantly negative due to multiple delayed SEC filings, an ongoing independent audit investigation, and non-compliance with NYSE listing standards. While extensions were granted, these issues indicate significant operational and governance challenges, creating substantial uncertainty for investors.

Positives

• The Company successfully negotiated an extension for the delivery of its audited annual financial statements for fiscal year 2024, providing more time to address the underlying issues.
• The NYSE granted an additional trading period until September 2, 2025, allowing the Company more time to file its delinquent reports and avoid immediate delisting.

Negatives

• The Company has multiple delinquent SEC filings, including its Q3 2024 10-Q, FY 2024 10-K, and Q1 2025 10-Q.
• The delays are due to an ongoing independent investigation by the Company's independent Audit Committee, indicating potential internal control or accounting issues.
• The Company is not in compliance with NYSE listing standards due to delayed filings and faces potential delisting if it cannot regain compliance by November 19, 2025.
• A new financial covenant requires maintaining a minimum of $100.0 million in unrestricted cash, which could restrict financial flexibility.

Risks

• The outcome of the ongoing independent investigation by the Audit Committee is uncertain and could lead to further disclosures, restatements, or other adverse consequences.
• There is a risk that the Company may not be able to file its Delinquent Filings within the extended NYSE deadlines, potentially leading to delisting from the New York Stock Exchange.
• The Company faces risks associated with litigation stemming from the investigation or delayed filings.
• The requirement to maintain at least $100.0 million in unrestricted cash could impact the Company's liquidity management and investment strategies.

Future Outlook

The Company intends to file its delinquent Quarterly Reports on Form 10-Q for Q3 2024 and Q1 2025, and its Annual Report on Form 10-K for FY 2024, and regain compliance with NYSE listing standards as soon as feasible and within the granted additional period. However, there is no assurance that the Company will ultimately regain compliance with all applicable NYSE listing standards.

Management Comments

• "The Company intends to file the Delinquent Filings and regain compliance as soon as feasible and within the granted additional period."

Industry Context

This announcement is specific to PACS Group, Inc.'s regulatory compliance and financial reporting issues. It does not directly provide broader industry trends or competitive analysis, but ongoing audit investigations and delayed filings can impact investor confidence across the healthcare services or long-term care industry, potentially leading to increased scrutiny for peers.

Corporate Governance

Legal Proceedings

• Ongoing independent investigation by the Company's independent Audit Committee, which is the stated reason for the delayed SEC filings.
• Forward-looking statements acknowledge risks associated with litigation, implying potential legal consequences related to the investigation or non-compliance.

Stakeholder Impact

• Shareholders: Face uncertainty due to delayed financial reporting, ongoing audit investigation, and the risk of delisting from the NYSE, which could negatively impact share price and liquidity.
• Lenders: Have agreed to modified covenants, including extended reporting deadlines and a new minimum cash requirement, indicating their involvement in managing the Company's financial stability during this period.
• Regulatory Authorities (SEC, NYSE): Are actively monitoring the Company's compliance with filing requirements and listing standards, with potential enforcement actions or delisting if compliance is not achieved.

Next Steps

• The Company intends to file its delinquent Quarterly Report on Form 10-Q for Q3 2024.
• The Company intends to file its delinquent Annual Report on Form 10-K for FY 2024.
• The Company intends to file its delinquent Quarterly Report on Form 10-Q for Q1 2025.
• The Company will work to regain compliance with NYSE listing standards by September 2, 2025, and ultimately by November 19, 2025.

Key Dates

Recommendation

Keywords

SEC filing, 8-K, credit agreement amendment, financial statements, NYSE non-compliance, delinquent filings, audit investigation, corporate governance, risk management, PACS Group